FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384345141> ?p ?o ?g. }

• W4384345141 endingPage "809" @default.
• W4384345141 startingPage "802" @default.
• W4384345141 abstract "Tyrosine kinase inhibitors (TKIs) have dramatically improved chronic myeloid leukemia (CML) prognosis. However, TKIs are associated with dyslipidemia and impaired glucosehomeostasis. Triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C) is proposed to be an indicator of insulin resistance and atherogenic index, but there is no research on TG/HDL-C alterations in patients receiving TKIs for CML. We aimed to evaluate relationships between TKI type/count, clinical characteristics, and laboratory results (particularly TG/HDL-C) in CML patients.A total of 104 patients with chronic phase CML were enrolled in the study. All patients received initial imatinib therapy at 400 mg daily, the type or dose of TKI was then changed according to treatment response and clinical outcomes. Patients were compared with respect to TG/HDL-C categorization (>2.5 versus <2.5), number of TKIs used, and use of imatinib as the only TKI.The median TG/HDL-C was 2.82 (1.03-17.33) and this ratio was higher than 2.5 in 59 (56.7%) patients. Patients with high TG/HDL-C had a significantly higher age than patients with low values (P < 0.001). Recipients of more than one TKI had higher EUTOS risk score and white blood cell (WBC) count (P < 0.05). Recipients of imatinib as the only TKI had higher age, low EOTUS risk score, low WBC, and low neutrophil count (all, P < 0.05).TG/HDL-C values were not associated with the number of different TKIs used or the use of imatinib only in chronic-phase patients with CML. Further large-scale prospective studies are needed to determine whether TG/HDL-C can be used for diagnostic or prognostic purposes in TKI recipients." @default.
• W4384345141 created "2023-07-15" @default.
• W4384345141 creator A5034936284 @default.
• W4384345141 creator A5038438257 @default.
• W4384345141 creator A5058625505 @default.
• W4384345141 creator A5092472852 @default.
• W4384345141 date "2023-06-01" @default.
• W4384345141 modified "2023-09-27" @default.
• W4384345141 title "Tyrosine Kinase Inhibitor Therapies in Chronic Myeloid Leukemia: Effects on Clinical Characteristics and Triglyceride-to-High Density Lipoprotein Cholesterol Ratio" @default.
• W4384345141 cites W1994630337 @default.
• W4384345141 cites W2028669471 @default.
• W4384345141 cites W2029260706 @default.
• W4384345141 cites W2074015360 @default.
• W4384345141 cites W2074198797 @default.
• W4384345141 cites W2130845505 @default.
• W4384345141 cites W2145899814 @default.
• W4384345141 cites W2254132687 @default.
• W4384345141 cites W2263396885 @default.
• W4384345141 cites W2300525540 @default.
• W4384345141 cites W2516360007 @default.
• W4384345141 cites W2766247589 @default.
• W4384345141 cites W2792592939 @default.
• W4384345141 cites W2886106314 @default.
• W4384345141 cites W2918115437 @default.
• W4384345141 cites W2924276146 @default.
• W4384345141 cites W2952306698 @default.
• W4384345141 cites W2985386710 @default.
• W4384345141 cites W2995455001 @default.
• W4384345141 cites W3009751715 @default.
• W4384345141 cites W3097949269 @default.
• W4384345141 cites W3111723671 @default.
• W4384345141 cites W3119368005 @default.
• W4384345141 cites W3157990394 @default.
• W4384345141 cites W3198415191 @default.
• W4384345141 cites W3216160339 @default.
• W4384345141 cites W4210893481 @default.
• W4384345141 cites W4285005610 @default.
• W4384345141 cites W4290995912 @default.
• W4384345141 cites W4293104079 @default.
• W4384345141 doi "https://doi.org/10.4103/njcp.njcp_755_22" @default.
• W4384345141 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37470656" @default.
• W4384345141 hasPublicationYear "2023" @default.
• W4384345141 type Work @default.
• W4384345141 citedByCount "0" @default.
• W4384345141 crossrefType "journal-article" @default.
• W4384345141 hasAuthorship W4384345141A5034936284 @default.
• W4384345141 hasAuthorship W4384345141A5038438257 @default.
• W4384345141 hasAuthorship W4384345141A5058625505 @default.
• W4384345141 hasAuthorship W4384345141A5092472852 @default.
• W4384345141 hasBestOaLocation W43843451411 @default.
• W4384345141 hasConcept C121608353 @default.
• W4384345141 hasConcept C126322002 @default.
• W4384345141 hasConcept C2777583451 @default.
• W4384345141 hasConcept C2778096610 @default.
• W4384345141 hasConcept C2778163477 @default.
• W4384345141 hasConcept C2778488018 @default.
• W4384345141 hasConcept C2778729363 @default.
• W4384345141 hasConcept C2778820342 @default.
• W4384345141 hasConcept C2778913445 @default.
• W4384345141 hasConcept C2779536868 @default.
• W4384345141 hasConcept C3019892230 @default.
• W4384345141 hasConcept C511355011 @default.
• W4384345141 hasConcept C71924100 @default.
• W4384345141 hasConcept C90924648 @default.
• W4384345141 hasConceptScore W4384345141C121608353 @default.
• W4384345141 hasConceptScore W4384345141C126322002 @default.
• W4384345141 hasConceptScore W4384345141C2777583451 @default.
• W4384345141 hasConceptScore W4384345141C2778096610 @default.
• W4384345141 hasConceptScore W4384345141C2778163477 @default.
• W4384345141 hasConceptScore W4384345141C2778488018 @default.
• W4384345141 hasConceptScore W4384345141C2778729363 @default.
• W4384345141 hasConceptScore W4384345141C2778820342 @default.
• W4384345141 hasConceptScore W4384345141C2778913445 @default.
• W4384345141 hasConceptScore W4384345141C2779536868 @default.
• W4384345141 hasConceptScore W4384345141C3019892230 @default.
• W4384345141 hasConceptScore W4384345141C511355011 @default.
• W4384345141 hasConceptScore W4384345141C71924100 @default.
• W4384345141 hasConceptScore W4384345141C90924648 @default.
• W4384345141 hasIssue "6" @default.
• W4384345141 hasLocation W43843451411 @default.
• W4384345141 hasLocation W43843451412 @default.
• W4384345141 hasLocation W43843451413 @default.
• W4384345141 hasOpenAccess W4384345141 @default.
• W4384345141 hasPrimaryLocation W43843451411 @default.
• W4384345141 hasRelatedWork W2015677102 @default.
• W4384345141 hasRelatedWork W2184534421 @default.
• W4384345141 hasRelatedWork W2184746615 @default.
• W4384345141 hasRelatedWork W2488200262 @default.
• W4384345141 hasRelatedWork W2563198120 @default.
• W4384345141 hasRelatedWork W3116441850 @default.
• W4384345141 hasRelatedWork W4230849756 @default.
• W4384345141 hasRelatedWork W4245675997 @default.
• W4384345141 hasRelatedWork W4319322290 @default.
• W4384345141 hasRelatedWork W2138415844 @default.
• W4384345141 hasVolume "26" @default.
• W4384345141 isParatext "false" @default.
• W4384345141 isRetracted "false" @default.
• W4384345141 workType "article" @default.